SwanBio Therapeutics

After a recent series B round, Beacon Therapeutics has boosted its finances by $170m, bringing its total funding to date to $290m, as it looks to advance in the crowded field of gene therapies for t

Decent-sized fundraisings have been few and far between in Europe of late but the Swiss/Dutch cancer specialist iOnctura SA has bucked the trend with a €80m series B financing. The round was led by

Keeping with the trend of combining companies to help financially constrained biotechs stay afloat, investment major Syncona has again come to the rescue of Freeline Therapeutics Holdings PLC and me

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Cidara Hopes For Early 2023 Approval Of